Going Solo Suits Vifor And Its Hopes For Two Blockbusters
Executive Summary
Enjoying its independence from Galenica, Switzerland’s third-largest pharmaceutical company believes that Ferinject and Veltassa will help it achieve sales of over CHF2bn by 2020.